These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35513541)

  • 1. Population pharmacokinetic analysis of sildenafil in term and preterm infants with pulmonary arterial hypertension.
    Rhee SJ; Shin SH; Oh J; Jung YH; Choi CW; Kim HS; Yu KS
    Sci Rep; 2022 May; 12(1):7393. PubMed ID: 35513541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of sildenafil in extremely premature infants.
    Gonzalez D; Laughon MM; Smith PB; Ge S; Ambalavanan N; Atz A; Sokol GM; Hornik CD; Stewart D; Mundakel G; Poindexter BB; Gaedigk R; Mills M; Cohen-Wolkowiez M; Martz K; Hornik CP;
    Br J Clin Pharmacol; 2019 Dec; 85(12):2824-2837. PubMed ID: 31475367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sildenafil in Term and Premature Infants: A Systematic Review.
    Perez KM; Laughon M
    Clin Ther; 2015 Nov; 37(11):2598-2607.e1. PubMed ID: 26490498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous sildenafil for treatment of early pulmonary hypertension in preterm infants.
    Schroeder L; Monno P; Strizek B; Dresbach T; Mueller A; Kipfmueller F
    Sci Rep; 2023 May; 13(1):8405. PubMed ID: 37225769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sildenafil in pediatric pulmonary arterial hypertension.
    Dhariwal AK; Bavdekar SB
    J Postgrad Med; 2015; 61(3):181-92. PubMed ID: 26119438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An opportunistic study evaluating pharmacokinetics of sildenafil for the treatment of pulmonary hypertension in infants.
    Thakkar N; Gonzalez D; Cohen-Wolkowiez M; Massaro MM; Bernhardt J; Zane NR; Laughon MM
    J Perinatol; 2016 Sep; 36(9):744-7. PubMed ID: 27171763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic interactions among imatinib, bosentan and sildenafil, and their clinical implications in severe pulmonary arterial hypertension.
    Renard D; Bouillon T; Zhou P; Flesch G; Quinn D
    Br J Clin Pharmacol; 2015 Jul; 80(1):75-85. PubMed ID: 25581063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension.
    Wirostko BM; Tressler C; Hwang LJ; Burgess G; Laties AM
    BMJ; 2012 Feb; 344():e554. PubMed ID: 22354598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sildenafil Exposure in the Neonatal Intensive Care Unit.
    Thompson EJ; Perez K; Hornik CP; Smith PB; Clark RH; Laughon M;
    Am J Perinatol; 2019 Feb; 36(3):262-267. PubMed ID: 30081404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.
    Shahin HI; Vinjamuri BP; Mahmoud AA; Shamma RN; Mansour SM; Ammar HO; Ghorab MM; Chougule MB; Chablani L
    J Control Release; 2019 May; 302():126-139. PubMed ID: 30940497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambrisentan for in pediatric pulmonary arterial hypertension: A cost-utility analysis.
    Buendía JA; Patiño DG; Lindarte EF
    Pediatr Pulmonol; 2023 May; 58(5):1562-1568. PubMed ID: 36797849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of sildenafil in premature infants with severe bronchopulmonary dysplasia (SILDI-SAFE): a multicenter, randomized, placebo-controlled, sequential dose-escalating, double-masked, safety study.
    Schneider S; Bailey M; Spears T; Esther CR; Laughon MM; Hornik CP; Jackson W
    BMC Pediatr; 2020 Dec; 20(1):559. PubMed ID: 33317479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertension.
    Barst RJ; Beghetti M; Pulido T; Layton G; Konourina I; Zhang M; Ivy DD;
    Circulation; 2014 May; 129(19):1914-23. PubMed ID: 24637559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sildenafil for the Treatment of Pulmonary Arterial Hypertension in Infants with Bronchopulmonary Dysplasia.
    Trottier-Boucher MN; Lapointe A; Malo J; Fournier A; Raboisson MJ; Martin B; Moussa A
    Pediatr Cardiol; 2015 Aug; 36(6):1255-60. PubMed ID: 25824807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Pharmacokinetics of Tadalafil in Pediatric Patients with Pulmonary Arterial Hypertension: A Combined Adult/Pediatric Model.
    Ferguson-Sells L; Velez de Mendizabal N; Li B; Small D
    Clin Pharmacokinet; 2022 Feb; 61(2):249-262. PubMed ID: 34379314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sildenafil exposure in neonates with pulmonary hypertension after administration via a nasogastric tube.
    Ahsman MJ; Witjes BC; Wildschut ED; Sluiter I; Vulto AG; Tibboel D; Mathot RA
    Arch Dis Child Fetal Neonatal Ed; 2010 Mar; 95(2):F109-14. PubMed ID: 19949232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension.
    Tang Y; Tan S; Li M; Tang Y; Xu X; Zhang Q; Fu Q; Tang M; He J; Zhang Y; Zheng Z; Peng J; Zhu T; Xie W
    BMC Pulm Med; 2022 Apr; 22(1):142. PubMed ID: 35413880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sildenafil for adult Asian patients with pulmonary arterial hypertension: a systematic review and meta-analysis.
    Shi Q; Wang Z; Yang N; Ma Y; Chen Y; Wei H; Yao H
    Ann Palliat Med; 2022 Jan; 11(1):339-351. PubMed ID: 35144425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review and cost-effectiveness of bosentan and sildenafil as therapeutic drugs for pediatric pulmonary arterial hypertension.
    Chen T; Chen J; Chen C; Zheng H; Chen Y; Liu M; Zheng B
    Pediatr Pulmonol; 2021 Jul; 56(7):2250-2258. PubMed ID: 33856119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral sildenafil and inhaled iloprost in the treatment of pulmonary hypertension of the newborn.
    Kahveci H; Yilmaz O; Avsar UZ; Ciftel M; Kilic O; Laloglu F; Ozturk K
    Pediatr Pulmonol; 2014 Dec; 49(12):1205-13. PubMed ID: 24420987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.